Microarray Madness | GenomeWeb

Microarray Madness

Premium

Macro coverage of microarrays. It’s what Marian Moser Jones does for BioArray News on a weekly basis, and it’s what we’ve pulled together this month for you in GT. For our cover story, Marian and senior editor Aaron J. Sender tag-teamed the Affymetrix execs — with Marian flying out to tour Affy’s Santa Clara HQ and Sacramento manufacturing facility and Aaron burning up the transcontintental cables spending hours in phone interviews with Sue Siegel and Steve Fodor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.